Giuliani, S.; Accetta, C.; di Martino, S.; De Vitis, C.; Messina, E.; Pescarmona, E.; Fanciulli, M.; Ciliberto, G.; Mancini, R.; Falcone, I.
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View. Pharmaceuticals 2025, 18, 853.
https://doi.org/10.3390/ph18060853
AMA Style
Giuliani S, Accetta C, di Martino S, De Vitis C, Messina E, Pescarmona E, Fanciulli M, Ciliberto G, Mancini R, Falcone I.
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View. Pharmaceuticals. 2025; 18(6):853.
https://doi.org/10.3390/ph18060853
Chicago/Turabian Style
Giuliani, Stefano, Celeste Accetta, Simona di Martino, Claudia De Vitis, Elena Messina, Edoardo Pescarmona, Maurizio Fanciulli, Gennaro Ciliberto, Rita Mancini, and Italia Falcone.
2025. "Metabolic Reprogramming in Melanoma: An Epigenetic Point of View" Pharmaceuticals 18, no. 6: 853.
https://doi.org/10.3390/ph18060853
APA Style
Giuliani, S., Accetta, C., di Martino, S., De Vitis, C., Messina, E., Pescarmona, E., Fanciulli, M., Ciliberto, G., Mancini, R., & Falcone, I.
(2025). Metabolic Reprogramming in Melanoma: An Epigenetic Point of View. Pharmaceuticals, 18(6), 853.
https://doi.org/10.3390/ph18060853
